Gain Therapeutics Q4 EPS $(0.11) Beats $(0.17) Estimate.
Benzinga Newsdesk 7 months ago
EarningsEarnings BeatsNews
Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.17) by 35.29 percent. This is unchanged from the same period last year.
Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.17) by 35.29 percent. This is unchanged from the same period last year.